Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

Share Price is delayed by 15 minutes
Get Live Data
362.50    3.50 (0.97%)
Bid:
362.50
Ask:
363.50
Spread: 1.00 (0.276%)
Market Cap: £1.20b
IHP Live PriceLast checked at - London Stock Exchange

Intraday IntegraFin Holdings Share Chart

Trading Statement

10 Nov 2022 07:00

RNS Number : 9086F
IntegraFin Holdings plc
10 November 2022
 

IntegraFin Holdings plc

IHP Group Trading Update ahead of full year 2022 results

For Immediate Release

10 November 2022

IntegraFin Holdings plc (''IHP'') today issues a Trading Update in respect of the financial year ended 30 September 2022. Overall, the Group is performing well, and we expect to report adjusted profit before tax for the full year which is moderately above the top end of the range of current analyst consensus estimates.

The uplift to our guidance reflects the Group's latest accounting updates including life insurance company calculations, provision releases, and other assessments. IHP is therefore now able to provide the following guidance on its results for the financial year ended 30 September 2022:

 

· Total Group revenue is expected to be £133.5m

 

· Net interest income is expected to be £0.6m as a result of interest rate tailwinds

 

· Tax recoveries relating to life insurance are expected to result in other income that is £0.2m higher than in the prior year

 

· Tax recoveries relating to research and development are expected to result in a credit to other costs of £0.3m

 

· Occupancy costs are expected to be £0.3m lower than the guidance we provided in July 2022, due to a one-off release of a dilapidation provision

 

· Staff costs are expected to be £0.7m lower than the guidance we provided in July 2022, due to the now agreed release of specific costs for the year ending 30 September 2022

 

The cost guidance for the financial years ending 30 September 2023, and 30 September 2024, remains unchanged.

We look forward to providing our year end results on 14 December 2022.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA")) ("UK MAR")

LEI Number: 213800CYIZKXK9PQYE87 

 

Enquiries

Luke Carrivick - IHP Head of Investor Relations +44 (0)20 7608 5463

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGBDBUXGDGDC
Date   Source Headline
17th Jun 20264:38 pmRNSHolding(s) in Company
22nd May 202610:49 amRNSDirector/PDMR Shareholding
21st May 20269:55 amRNSDirector/PDMR Shareholding
20th May 20267:00 amRNSHalf-year Financial Report
7th May 20263:35 pmRNSHolding(s) in Company
22nd Apr 20263:35 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSQ2 Trading Update
10th Apr 202610:24 amRNSHolding(s) in Company
30th Mar 202611:39 amRNSHolding(s) in Company
24th Mar 202610:49 amRNSDirector/PDMR Shareholding
16th Mar 20263:39 pmRNSHolding(s) in Company
16th Mar 20263:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSResult of AGM
24th Feb 20264:13 pmRNSDirector/PDMR Shareholding
23rd Feb 20269:45 amRNSHolding(s) in Company
19th Feb 202612:06 pmRNSHolding(s) in Company
12th Feb 202612:14 pmRNSDirector/PDMR Shareholding
2nd Feb 202612:39 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:14 pmRNSDirector/PDMR Shareholding
13th Jan 20265:09 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS1st Quarter Results
9th Jan 202611:49 amRNSAnnual Financial Report
30th Dec 202512:49 pmRNSHolding(s) in Company
30th Dec 202512:49 pmRNSHolding(s) in Company
24th Dec 202511:14 amRNSDirector/PDMR Shareholding
24th Dec 202511:14 amRNSDirector/PDMR Shareholding
19th Dec 202512:30 pmRNSDirector/PDMR Shareholding
19th Dec 202512:30 pmRNSDirector/PDMR Shareholding
18th Dec 202512:59 pmRNSDirector/PDMR Shareholding
18th Dec 202512:59 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSFinal Results
25th Nov 20259:45 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSReplacement: Holding(s) in Company
6th Nov 20254:03 pmRNSHolding(s) in Company
3rd Nov 20253:03 pmRNSHolding(s) in Company
28th Oct 20255:17 pmRNSHolding(s) in Company
22nd Oct 20255:02 pmRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSQ4 Trading Update
10th Oct 20251:46 pmRNSHolding(s) in Company
29th Sep 20254:40 pmRNSDirector/PDMR Shareholding
23rd Sep 202511:26 amRNSDirector/PDMR Shareholding
22nd Sep 202511:15 amRNSHolding(s) in Company
19th Sep 202512:46 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 202512:00 pmRNSChange of Registered Office
1st Sep 202512:00 pmRNSHolding(s) in Company
26th Aug 202510:35 amRNSDirector/PDMR Shareholding
11th Aug 20253:29 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
23rd Jul 20254:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.